Robert Hoffman
2017
In 2017, Robert Hoffman earned a total compensation of $2.3M as Chief Financial Officer and Senior Vice President, Finance at Heron Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $68,425 |
|---|---|
| Option Awards | $1,972,207 |
| Salary | $235,577 |
| Other | $3,635 |
| Total | $2,279,844 |
Hoffman received $2M in option awards, accounting for 87% of the total pay in 2017.
Hoffman also received $68.4K in non-equity incentive plan, $235.6K in salary and $3.6K in other compensation.
Rankings
In 2017, Robert Hoffman's compensation ranked 4,874th out of 14,666 executives tracked by ExecPay. In other words, Hoffman earned more than 66.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,874 out of 14,666 | 67th |
Division Manufacturing | 1,739 out of 5,772 | 70th |
Major group Chemicals And Allied Products | 518 out of 2,075 | 75th |
Industry group Drugs | 401 out of 1,731 | 77th |
Industry Pharmaceutical Preparations | 320 out of 1,333 | 76th |
Source: SEC filing on April 23, 2020.
Hoffman's colleagues
We found three more compensation records of executives who worked with Robert Hoffman at Heron Therapeutics in 2017.